Citation: M. Notelovitz et Jh. Mattox, Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol, MENOPAUSE, 7(5), 2000, pp. 310-317
Authors:
Taggart, W
Dandekar, K
Ellman, H
Notelovitz, M
Citation: W. Taggart et al., The effect of site of application on the transcutaneous absorption of 17-beta estradiol from a transdermal delivery system (Climara), MENOPAUSE, 7(5), 2000, pp. 364-369
Authors:
Notelovitz, M
Cassel, D
Hille, D
Furst, KW
Dain, MP
VandePol, C
Skarinsky, D
Citation: M. Notelovitz et al., Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause, AM J OBST G, 182(1), 2000, pp. 7-12
Authors:
Barrett-Connor, E
Young, R
Notelovitz, M
Sullivan, J
Wiita, B
Yang, HM
Nolan, J
Citation: E. Barrett-connor et al., A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women - Effects on bone mineral density, symptoms and lipid profiles, J REPRO MED, 44(12), 1999, pp. 1012-1020